21 employees
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
2021
$50M
from 4 investors over 4 rounds
XinThera Inc. raised $50M on August 4, 2021
Investors: Foresite Capital, OrbiMed Advisors and TTM Capital, LLC
XinThera Inc. raised undisclosed on May 1, 2021
Investors: TTM Capital, LLC